To reveal the role of the ribosomal protein p70S6K1 in invasive BC progression in (T2)DM patients, particularly involving cell invasion processes, siRNA transfection technology was first applied to downregulate p70S6K1 expression in highly invasive TNBC cell line MDA-MB-231. This evidence concerns the gene RPS6KB1 and breast cancer.